CDE Detailed Report

Disease: content
Subdomain Name: Neurological Outcomes
CRF: welcome

Displaying 1 - 4 of 4
CDE ID CDE Name Variable Name Definition Short Description Question Text Permissible Values Description Data Type Disease Specific Instructions Disease Specific Reference Population Classification (e.g., Core) Version Number Version Date CRF Name (CRF Module / Guidance) Subdomain Name Domain Name Size Input Restrictions Min Value Max Value Measurement Type External Id Loinc External Id Snomed External Id caDSR External Id CDISC
C11964 Tardieu Scale relative velocity rate TardieuScaleRltvVelocRt The relative velocity (for a repeated measure) during administration of the Tardieu Scale assessment to measure muscle reaction through evaluation of spasticity and resistance to passive limb movement in a participant/subject The relative velocity (for a repeated measure) during administration of the Tardieu Scale assessment to measure muscle reaction through evaluation of spasticity and resistance to passive limb movement in a participant/subjec Velocity 1;2;3 V1 - As slow as possible, slower than the natural drop of the limb segment under gravity;V2 - Speed of limb segment falling under gravity;V3 - As fast as possible, faster than the rate of the natural drop of the limb segment under gravity Numeric Values

Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.

Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143&#8211;144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007&#8211;1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23&#8211;S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421&#8211;428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899&#8211;907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53&#8211;62. Adult;Pediatric Exploratory 3.00 2013-07-22 16:57:17.79 Tardieu Scale Neurological Outcomes Outcomes and End Points

Single Pre-Defined Value Selected

C11965 Tardieu Scale movement resistance score TardieuScaleMovmntResistScore The semi-quantitative score describing relative resistance to passive limb movement or occurrence of spasticity observed while administering the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject The semi-quantitative score describing relative resistance to passive limb movement or occurrence of spasticity observed while administering the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subjec X 0;1;2;3;4;5 No resistance throughout the course of the passive movement;Slight resistance throughout the course of passive movement, no clear catch at a precise angle;Clear catch at a precise angle, interrupting the passive movement, followed by release;Fatigable clonus with less than 10 seconds when maintaining the pressure and appearing at the precise angle;Unfatigable clonus with more than 10 seconds when maintaining the pressure and appearing at a precise angle;Joint is immovable (Indicate which assistive device the participant uses) Numeric Values

Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.

Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143&#8211;144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007&#8211;1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23&#8211;S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421&#8211;428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899&#8211;907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53&#8211;62. Adult;Pediatric Exploratory 3.00 2013-07-22 16:57:17.79 Tardieu Scale Neurological Outcomes Outcomes and End Points

Single Pre-Defined Value Selected

C11966 Tardieu Scale muscle reaction angle measurement TardieuScaleMuscReactAngMeasr The degree of angle for limb position at which muscle reaction or spasticity occurs for a given velocity administered during the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject The degree of angle for limb position at which muscle reaction or spasticity occurs for a given velocity administered during the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subjec Y (Degree of angle at which muscle reaction occurs) Numeric Values

Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.

Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143&#8211;144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007&#8211;1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23&#8211;S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421&#8211;428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899&#8211;907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53&#8211;62. Adult;Pediatric Exploratory 3.00 2013-07-22 16:57:17.79 Tardieu Scale Neurological Outcomes Outcomes and End Points

Free-Form Entry

0 180 degree of arc
C17541 Tardieu Scale assistive device text TardieuScaleAssistDevTxt Text identifying an assistive device used by the participant/subject for an immovable joint in a limb Text identifying an assistive device used by the participant/subject for an immovable joint in a lim Indicate which assistive device the participant uses Alphanumeric Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143&#8211;144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007&#8211;1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23&#8211;S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421&#8211;428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899&#8211;907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53&#8211;62. Adult;Pediatric Exploratory 3.00 2013-07-15 16:08:48.687 Tardieu Scale Neurological Outcomes Outcomes and End Points 255

Free-Form Entry

CSV